Oncology & Cancer
Counting cancerous lymph nodes is best lymphoma predictor
Patients newly diagnosed with cancer typically focus on one question, eclipsing all others: "What is my prognosis?"
Jun 3, 2022
0
7
Page 17 - News tagged with prostate tumor
Oncology & Cancer
Why prostate cancer is more aggressive in obese patients
Obesity has direct consequences on health and is associated with the onset of aggressive cancers, but the mechanisms underlying this phenomenon are little known. Researchers from the Institut de Pharmacologie et Biologie ...
Jan 13, 2016
0
56
Oncology & Cancer
Researchers report a new target to treat prostate cancer
The drug Gefitinib is used to treat breast, lung, and other cancers by inhibiting epidermal growth factor receptor (EGFR) signaling, but it has only a limited effect on prostate cancer. EGFR, present on the cell membrane, ...
Dec 22, 2017
0
5
Oncology & Cancer
One single biopsy not sufficient to guide treatment decisions in prostate cancer
While the majority of prostate cancers are slow growing and not fatal, some are aggressive and lethal. Genomic fingerprinting can help predict a tumor's aggressiveness and tailor treatment plans; however, in the majority ...
Sep 22, 2016
0
2
Oncology & Cancer
Largest study of prostate cancer genomics in Black Americans IDs targets for therapies
Black men in the United States are known to suffer disproportionately from prostate cancer, but few studies have investigated whether genetic differences in prostate tumors could have anything to do with these health disparities.
Jul 10, 2020
0
75
Oncology & Cancer
Interim scan during prostate cancer therapy helps guide treatment
New prostate cancer research shows that adding an interim scan during therapy can help guide a patient's treatment. Prostate-specific membrane antigen (PSMA) positron emission tomography (PET) imaging of patients with metastatic ...
Jun 24, 2019
0
0
Oncology & Cancer
Oxygen in tumors predicts prostate cancer recurrence
Low oxygen levels in tumors can be used to predict cancer recurrence in men with intermediate-risk prostate cancer even before they receive radiation therapy.
Apr 1, 2012
0
0
Oncology & Cancer
Scientists develop powerful new animal model for metastatic prostate cancer
Prostate cancer is the most common form of cancer in men. Affecting about 1 in 6 men, it is the second deadliest cancer. Research has been stymied by imperfect animal models of the disease, which are costly, take considerable ...
Jan 24, 2014
0
0
Oncology & Cancer
STD may heighten risk of prostate cancer
(Medical Xpress)—Could a common sexually transmitted infection boost a man's risk for prostate cancer?
May 28, 2014
0
0
Oncology & Cancer
Neuronal molecule makes prostate cancer more aggressive
Prostate cancer is the second most common cancer and the second leading cause of cancer death among American men. Now, researchers have discovered key molecular players that drive prostate cancer to progress into a highly ...
Jan 24, 2023
0
29
